NASDAQ: GYRE - Gyre Therapeutics, Inc.

Rentabilité sur six mois: +3.06%
Rendement en dividendes: 0.00%

Calendrier des promotions Gyre Therapeutics, Inc.

Calendrier avancé Graphique simple
Financial Markets by TradingView

À propos de l'entreprise Gyre Therapeutics, Inc.

Gyre Therapeutics, Inc., a pharmaceutical company, engages in the development and commercialization of small-molecule, anti-inflammatory, and anti-fibrotic drugs targeting organ fibrosis. It offers ETUARY (Pirfenidone), an anti-fibrotic drug approved for the treatment of idiopathic pulmonary fibrosis; and under phase 3 studies for dermatomyositis and systemic sclerosis-associated interstitial lung disease, pneumoconiosis, and diabetic kidney disease.

plus de détails
The company is also involved the development of F351 (Hydronidone), a structural derivative of ETUARY (Pirfenidone), under Phase 3 studies for the treatment of chronic hepatitis B liver fibrosis; and under Phase 1 studies for liver fibrosis associated with nonalcoholic associated steatohepatitis. In addition, its development pipeline includes F573, under Phase 2 studies for the treatment of acute/acute-on-chronic liver failure; F528, under preclinical stage for the treatment of chronic obstructive pulmonary disease; and F230, under preclinical stage for the treatment of pulmonary arterial hypertension. The company was founded in 2002 and is headquartered in San Diego, California. Gyre Therapeutics, Inc. operates as a subsidiary of GNI USA, Inc.
Ajouter à la liste de comparaison
Ajouter à la liste de surveillance
Ajouter au portefeuille
Ajouter un avis de prix

IPO date 2006-04-12
ISIN US4037831033
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Див.доход ао 0
Дивиденд ао 25.05
Сайт https://www.gyretx.com
Цена ао 16.79
Changement de prix par jour: -5.18% (13.13)
Changement de prix par semaine: +11.76% (11.14)
Changement de prix par mois: +6.41% (11.7)
Changement de prix sur 3 mois: -2.43% (12.76)
Changement de prix sur six mois: +3.06% (12.08)
Changement de prix par an: -51.54% (25.69)
Evolution du prix sur 3 ans: +516.34% (2.02)
Evolution du prix sur 5 ans: +12.36% (11.08)
Evolution des prix sur 10 ans: 0% (12.45)
Evolution des prix depuis le début de l'année: +10.27% (11.29)
Tous les paramètres

Sous-estimation

Nom Signification Grade
P/S 17.22 1
P/BV 140.07 1
P/E 0 0
EV/EBITDA 16.55 6
Total: 2.13

Efficacité

Nom Signification Grade
ROA, % -79.74 0
ROE, % 587.14 10
Total: 5

Dividendes

Nom Signification Grade
Div yield, % 0 0
DSI 0.5 5
Total: 2.22

Devoir

Nom Signification Grade
Debt/EBITDA 0.0035 10
Total: 10

Impulsion de croissance

Nom Signification Grade
Rentabilité Revenue, % 1890733.33 10
Rentabilité Ebitda, % -347.89 0
Rentabilité EPS, % 123.83 10
Total: 6
Plus de détails

Établissements Volume Partager, %
Renaissance Technologies, LLC 39379 0.1
Geode Capital Management, LLC 17250 0.05
Vanguard Group Inc 13793 0.04
Blackrock Inc. 10250 0.03
Citigroup Inc. 7748 0.02
Morgan Stanley 6516 0.02
Kynam Capital Management, LP 6004 0.02
Northern Trust Corporation 5761 0.02
State Street Corporation 4840 0.01
Nantahala Capital Management, LLC 4520 0.01

ETF Partager, % Rentabilité pour l'année, % Dividendes, %
iShares Morningstar Small Cap Value ETF 0.00477 26.7 2.50476
iShares Morningstar Small-Cap Value ETF 0.00477 201.65 2.50476
iShares Morningstar Small-Cap ETF 0.00416 30.1 1.60498
iShares Morningstar Small-Cap ETF 0.00416 391.25 1.60498
iShares Morningstar Small-Cap Growth ETF 0.00411 33.63 0.72598
iShares Morningstar Small-Cap Growth ETF 0.00411 587.89 0.72598

Superviseur Titre d'emploi Paiement Année de naissance
Dr. Han Ying Ph.D. CEO & Director 10.5k 1966 (59 années)
Mr. Songjiang Ma President & Director N/A 1956 (69 années)
Ms. Ruoyu Chen Chief Financial Officer 121.35k 1971 (54 année)
Mr. Weiguo Ye Chief Operating Officer 274.62k 1978 (47 années)
Ms. Seline E. Miller CPA Senior Vice President of Finance N/A 1970 (55 années)

Adresse: United States, San Diego. CA, 12770 High Bluff Drive - ouvrir dans Google Maps, ouvrir les cartes Yandex
Site web: https://www.gyretx.com